STOCK TITAN

Vireo Growth Inc. to Release Second Quarter 2025 Results on August 13, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Vireo Growth (OTCQX: VREOF) has scheduled its second quarter 2025 financial results release for August 13, 2025, before market opening. The company will host a conference call with investors on the same day at 8:30 a.m. ET to discuss the quarterly performance.

Investors can join the call by dialing 1-800-715-9871 (US/Canada toll-free) or 1-646-307-1963 (International) with conference ID 3718174. A live webcast will be available through the company's Investor Relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+7.35% News Effect

On the day this news was published, VREOF gained 7.35%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its second fiscal quarter ended June 30, 2025 on Wednesday, August 13, 2025 before the market opens.

Vireo Growth management will host a conference call with the investment community that same day, Wednesday, August 13, 2025 at 8:30 a.m. ET (7:30 a.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 3718174.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link:
https://events.q4inc.com/attendee/687371440.

About Vireo Growth Inc.

Vireo was founded in 2014 as a medical cannabis pioneer—and we’ve never stopped pushing boundaries. We’re building the most disciplined, strategically aligned, and execution-focused platform in the industry. That means staying relentlessly local while leveraging the strength of a national portfolio, backing exceptional leaders, and deploying capital and talent where it drives the most value. Vireo operates with a long-term mindset, a bias for action, and an unapologetic commitment to its customers, employees, shareholders, industry collaborators, and the communities it calls home. For more information about Vireo, visit www.vireogrowth.com.

Contact Information

Joe Duxbury
Chief Accounting Officer
investor@vireogrowth.com
(612) 314-8995


FAQ

When will Vireo Growth (VREOF) release Q2 2025 earnings?

Vireo Growth will release its Q2 2025 financial results on Wednesday, August 13, 2025 before the market opens.

How can investors join Vireo Growth's Q2 2025 earnings call?

Investors can join by dialing 1-800-715-9871 (US/Canada toll-free) or 1-646-307-1963 (International) with conference ID 3718174, or watch the webcast through the company's IR website.

What time is Vireo Growth's Q2 2025 earnings call?

The earnings conference call is scheduled for Wednesday, August 13, 2025 at 8:30 a.m. ET (7:30 a.m. CT).

Where can I access the webcast of Vireo Growth's Q2 2025 earnings call?

The live audio webcast will be available in the Events & Presentations section of Vireo Growth's Investor Relations website and through their dedicated event link.
Vireo Growth Inc

OTC:VREOF

VREOF Rankings

VREOF Latest News

VREOF Latest SEC Filings

VREOF Stock Data

438.51M
762.00M
23.53%
12.66%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Minneapolis